HomeInsightsStock Comparison

Piramal Pharma Ltd vs Sms Lifesciences India Ltd Stock Comparison

Piramal Pharma Ltd vs Sms Lifesciences India Ltd Stock Comparison

Last Updated on: May 20, 2025

Key Highlights

  • The Latest Trading Price of Piramal Pharma Ltd is ₹ 205.3 as of 20 May 10:05.
  • The P/E Ratio of Piramal Pharma Ltd changed from 991.5 on March 2024 to 991.5 on March 2024 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of SMS Lifesciences India Ltd changed from 5.2 on March 2020 to 22.6 on March 2024 . This represents a CAGR of 34.16% over 5 years.
  • The Market Cap of Piramal Pharma Ltd changed from ₹ 8165 crore on March 2023 to ₹ 17052 crore on March 2024 . This represents a CAGR of 44.51% over 2 yearsThe Market Cap of SMS Lifesciences India Ltd changed from ₹ 52.91 crore on March 2020 to ₹ 205.21 crore on March 2024 . This represents a CAGR of 31.14% over 5 years.
  • The revenue of Piramal Pharma Ltd for the Mar '25 is ₹ 2812 crore as compare to the Dec '24 revenue of ₹ 2233 crore. This represent the growth of 25.92% The revenue of SMS Lifesciences India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 84.66 crore. This represent the decline of -100%.
  • The ebitda of Piramal Pharma Ltd for the Mar '25 is ₹ 619.24 crore as compare to the Dec '24 ebitda of ₹ 366.92 crore. This represent the growth of 68.77% The ebitda of SMS Lifesciences India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 12.81 crore. This represent the decline of -100%.
  • The net profit of Piramal Pharma Ltd changed from ₹ -98.58 crore to ₹ 153.5 crore over 8 quarters. This represents a CAGR of NaN% The net profit of SMS Lifesciences India Ltd changed from ₹ -3.83 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Piramal Pharma Ltd changed from 18.07 % on March 2022 to 3.72 % on March 2024 . This represents a CAGR of -40.95% over 3 yearsThe Dividend Payout of SMS Lifesciences India Ltd changed from 3.44 % on March 2021 to 3.47 % on March 2024 . This represents a CAGR of 0.22% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Piramal Pharma Ltd

  • Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries.
  • It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India.
  • In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. PPL is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.
  • It operate under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization (CDMO) having a product suite in niche areas such as highly potent Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), antibody drug conjugates, potent sterile injectable, hormonal oral solid dosage forms, biologics and vaccines; Piramal Critical Care, a complex hospital generics (CHG) business in the areas of inhalation anaesthesia, injectable anaesthesia and pain management, intrathecal therapy and other injectable; and India consumer healthcare (ICH) business, selling well-known OTC brands.

About SMS Lifesciences India Ltd

  • SMS Lifesciences India Limited was incorporated originally as 'Potluri Real Estate Private Limited' on May 31, 2006.
  • The Company's name was changed to 'Potluri Packaging Industries Private Limited' on 6 November, 2013 and again changed to 'SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector.
  • The Company became a wholly owned subsidiary Company of SMS Pharmaceuticals Limited w.e.f. 01.04.2016 and subsequently got converted into a Public Limited w.e.f. 22 June, 2016. The Company is engaged in the business of manufacturing and export of Active Pharma Ingredients(APIs) and their intermediates.
  • The Company is having manufacturing facilities at Kazipally and Jeedimetla, Hyderabad with an installed capacity of 65 KL. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having products spread across an array of therapeutic segments.

Piramal Pharma Ltd News Hub

News

Board of Piramal Pharma recommends final dividend

Piramal Pharma announced that the Board of Directors of the Company at its meeting held on...

Read more

15 May 2025 10:18

News

Piramal Pharma's Turbhe facility successfully completes USFDA inspection

Piramal Pharma announced that the USFDA has issued an Establishment Inspection Report (EIR...

Read more

12 May 2025 12:47

News

Piramal Pharma gains after receiving EIR for Turbhe facility from USFDA

According to the company's exchange filing, the US FDA conducted a general Good Manufactur...

Read more

12 May 2025 15:39

News

Piramal Pharma to conduct board meeting

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 14 May 2025...

Read more

30 Apr 2025 10:45

News

Piramal Pharma's Telangana unit starts production of general anesthesia drug Sevoflurane

This was achieved by creating capacity for Sevoflurane manufacture at the Digwal facility ...

Read more

02 Apr 2025 11:25

News

Piramal Pharma Ltd Spurts 3.8%

Piramal Pharma Ltd rose 3.8% today to trade at Rs 229.65. The BSE Healthcare index is up 0...

Read more

21 Mar 2025 09:30

SMS Lifesciences India Ltd News Hub

News

SMS Lifesciences India spurts as Q3 PAT jumps 18% YoY to Rs 5 cr

Revenue from operations was at Rs 84.60 crore in the third quarter of FY25, marking a grow...

Read more

13 Feb 2025 12:51

News

SMS LifeSciences India to announce Quarterly Result

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 12 ...

Read more

08 Feb 2025 16:22

News

SMS LifeSciences India to conduct board meeting

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 13 ...

Read more

09 Nov 2024 12:30

News

SMS LifeSciences India AGM scheduled

SMS LifeSciences India announced that the 18th Annual General Meeting (AGM) of the company...

Read more

20 Aug 2024 16:03

News

SMS LifeSciences India schedules board meeting

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 9 A...

Read more

08 Aug 2024 17:18

News

Board of SMS LifeSciences India recommends final dividend

SMS LifeSciences India announced that the Board of Directors of the Company at its meeting...

Read more

28 May 2024 10:59

SWOT Analysis Of Piramal Pharma Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of SMS Lifesciences India Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Piramal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for SMS Lifesciences India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Piramal Pharma Ltd and SMS Lifesciences India Ltd

Which company has a larger market capitalization, Piramal Pharma Ltd or SMS Lifesciences India Ltd?

Market cap of Piramal Pharma Ltd is 27,257 Cr while Market cap of SMS Lifesciences India Ltd is 393 Cr

What are the key factors driving the stock performance of Piramal Pharma Ltd and SMS Lifesciences India Ltd?

The stock performance of Piramal Pharma Ltd and SMS Lifesciences India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Piramal Pharma Ltd and SMS Lifesciences India Ltd?

As of May 20, 2025, the Piramal Pharma Ltd stock price is INR ₹205.6. On the other hand, SMS Lifesciences India Ltd stock price is INR ₹1301.75.

How do dividend payouts of Piramal Pharma Ltd and SMS Lifesciences India Ltd compare?

To compare the dividend payouts of Piramal Pharma Ltd and SMS Lifesciences India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions